Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cells†
Abstract
A biotin-guided platinumIV complex is highly cytotoxic against breast cancer cells but hypotoxic against mammary epithelial cells. The mono-biotinylated PtIV complex is superior to the di-biotinylated one and hence a promising drug candidate for the targeted therapy of breast cancer.